We write this letter as a brief report of our personal observation on the relationship between basal insulin requirement and body mass index (BMI) in children and adults with type 1 diabetes on insulin pump therapy.
In adults, the relationship between increased weight and insulin resistance is well established. Studies have also proven the coexistence of insulin resistance and hyperinsulinemia in preadolescent obese children.1 Accordingly, it is plausible that higher BMI results in increasing basal insulin requirement. However, studies show contradicting results on the correlation between BMI and the basal insulin portion of the total daily insulin.2-4 In the pediatric age group, it is recommended that basal insulin compose 30% to 50% of the total daily dose with consideration of the age-dependent circadian variations.5 We hypothesize that higher basal insulin is required for patients with higher BMI, and we report our observation on the relationship in children and adults with type 1 diabetes on insulin pump therapy. We have looked at this relationship in a group of children and adults on insulin pump therapy. We have divided the subjects into normal and overweight based on their BMI. Children’s classification into either normal weight, overweight, or obese was based on their BMI centile plotted in the CDC BMI chart. Basal insulin dose is considered high if it exceeds 50% of the total daily insulin. The observed population consisted of 50 children and 22 adults with type 1 diabetes on insulin pump therapy. Of the subjects, 63% were of normal weight and 37% were overweight. None were obese.
We observed no differences in the number of normal weight or overweight patients on basal insulin ratio of over 50%. This observation was seen in both children and adults. HbA1c, total daily insulin, and carbohydrate intake showed no significant difference in those with low basal insulin requirement compared to others with higher requirement. However, higher basal insulin requirement was observed in older children (P = .031) (Table 1).
Table 1.
The Association Between Basal Insulin Ratio and Continuous Variables: Age, HbA1c, Daily Insulin per kg Body Weight, and Daily Carbohydrate Intake in the Children Group.
| Basal insulin ratio | N | Median (range) | P value | |
|---|---|---|---|---|
| Age | ≤50% | 24 | 10.5 (2.3-16.8) | .031 |
| >50% | 26 | 12.9 (4.4-17.1) | ||
| HbA1C | ≤50% | 24 | 8.2% (5.8-11.8) 66.1 mmol/mol (39.9-105.5) | .180 |
| >50% | 26 | 8.6% (6.9-11.7) 70.5 mmol/mol (51.9-104.4) | ||
| Daily insulin/kg | ≤50% | 24 | 0.84 (0.59-1.15) | .547 |
| >50% | 26 | 0.87 (0.44-1.13) | ||
| Daily CHO | ≤50% | 24 | 189.5 (95-401) | .159 |
| >50% | 26 | 165.5 (79-330) |
Besides BMI, other factors influence basal insulin requirement. Meal content is shown to affect the bolus basal ratio of insulin. In a group of adolescents with type 1 diabetes from Japan, daily basal insulin dose was found to correlate with fat energy ratio of meals.6 In our region, diet is rich in fat and high glycemic index carbohydrate. We have not looked at the meal contents in the observed population, but we assume that it might be a factor influencing the split of the total daily insulin into boluses and basal.
Based on our observation, we conclude that BMI is not a predictive factor for basal insulin requirement in patients with type 1 diabetes. We highlight that puberty has an impact on basal insulin requirement regardless of the BMI, total insulin requirement, or daily carbohydrate intake. These clinical observations need to be confirmed on a larger population with consideration of meal contents and ideally by using a glucose clamp under controlled condition.
Footnotes
Abbreviations: BMI, body mass index; CDC, Centers for Disease Control and Prevention; HbA1c, hemoglobin A1c.
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Funding: The author(s) received no financial support for the research, authorship, and/or publication of this article.
References
- 1. Bronson CM, Sherwin RS, Rife F, et al. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia. 1996;39(12):1489-1497. [DOI] [PubMed] [Google Scholar]
- 2. Phillip M, Battelino T, Rodriguez H, et al. Use of insulin pump therapy in the pediatric age-group. Consensus statement from the European Society for Paediatric Endocrinology, the Lawson Wilkins Pediatric Endocrine Society, and the International Society for Pediatric and Adolescent Diabetes, endorsed by the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2007;30(6):1653-1662. [DOI] [PubMed] [Google Scholar]
- 3. Szypowska A, Lipka M, Błazik M, et al. Age-dependent basal insulin patterns in children with type 1 diabetes treated with continuous subcutaneous insulin infusion. Acta Paediatr. 2009;98(3):523-526. [DOI] [PubMed] [Google Scholar]
- 4. Pankowska E, Szypowska A, Lipka M. Basal insulin and total daily insulin dose in children with type 1 diabetes using insulin pumps. Pediatr Diabetes. 2008;9:208-213. [DOI] [PubMed] [Google Scholar]
- 5. Bachran R, Beyer P, Klinkert C, et al. Basal rates and circadian profiles in continuous subcutaneous insulin infusion (CSII) differ for preschool children, prepubertal children, adolescents and young adults. Pediatr Diabetes. 2012;13(1):1-5. [DOI] [PubMed] [Google Scholar]
- 6. Hashimoto T, Kawamura T, Kashihara Y, et al. Factors associated with basal insulin dose in Japanese children and young adult type 1 diabetes. J Diabetes Invest. 2012;3:276-281. [DOI] [PMC free article] [PubMed] [Google Scholar]